With ever-increasing costs to put a single molecule on the market, the pressure to reach clinical milestones quickly and ...

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

Hello, and welcome to Washington Post Live. I’m Frances Stead Sellers, an associate editor here at The Washington Post. Today we have two segments on the future of cancer care. In a little while, I'll ...

"I just liked working with them so much that I joined them," Chen told BioWorld. Today, Chen is co-CEO of WuXi AppTec. The company, which started with a laboratory of 7,000 square feet, has grown into ...

Although a start-up's recent triumph is seen as a 'DeepSeek moment', domestic players still trail world-beating pharma firms, ...

New work shows that physical folding of the genome to control genes located far away may have been an early evolutionary ...

Your DNA contains millions of genetic variants that interact with each other in ways that affect whether diseases such as ...

The genetic roots of a disease or disorder do not always grow into clear cut, easily diagnosed clinical features.

Lucas Downey is the co-founder of MoneyFlows, and an Investopedia Academy instructor. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who has been working in ...